Abstract
In this study, the establishment and validation of a stable reversed-phase high-performance liquid chromatography (RP-HPLC) method for the concomitant estimation of the two drugs in dosage forms are presented. Method optimization was achieved by response surface methodology (RSM) using Design Expert Software 13, taking into account the special physicochemical characteristics of metoclopramide (MET) (a moderately polar molecule, pKa 9.5) and camylofin (CAM) (a less polar, hydrophobic molecule, pKa 8.7). Chromatographic resolution was achieved on a phenyl-hexyl column under isocratic mobile phase mode in which methanol and 20 mM ammonium acetate buffer (pH 3.5) were used to provide maximum analyte interaction and resolution. The method was found to have good linearity for both analytes (R2 > 0.999) over the concentration ranges studied. Limits of detection were 0.23 and 0.15 μg/mL for MET and CAM, respectively, and corresponding limits of quantification were 0.35 and 0.42 μg/mL, respectively. Recovery tests gave high precision values of 98.2%–101.5%, while intra- and inter-day precision in relative standard deviation (RSD) was below 2%. The method was effectively applied for the analysis of commercial tablet formulations, confirming its reliability and suitability for routine quality control and regulatory analyses. Overall, the validated RP-HPLC method provides a sensitive, accurate, and efficient means of simultaneous determination of MET and CAM in pharmaceutical dosage forms.
Keywords: camylofin, chromatographic separation, HPLC method development, metoclopramide, response surface methodology
1. Introduction
Metoclopramide (MET) and camylofin (CAM) are commonly co-administered drugs used in the treatment of gastrointestinal disease, with a synergistic therapeutic advantage. MET, an antagonist of dopamine receptors, exhibits antiemetic and motility-stimulating properties, while CAM is a smooth muscle relaxant and antispasmodic agent [1–3]. MET is a dopamine receptor antagonist that primarily acts as an antiemetic and enhances movement. Conversely, CAM relaxes the smooth muscles of the GI tract and stops spasms. Since these compounds function complementarily, their discovery and assay together have prime importance in pharmaceutical formulations, ensuring their safety, efficacy, and regulatory compliance [4, 5].
MET (C14H22ClN3O2, pKa 9.5) is a moderately polar hydrophilic compound with a substituted benzamide framework, readily soluble in polar organic solvents. CAM (C19H30N2O2, pKa 8.7) contains a bicyclohexane ring system with ester functionality and hydrophobic character, with preferred solubility in nonpolar solvents. Such chemical diversity presents immense analytical challenges for simultaneous determination, and therefore, optimized chromatographic conditions are required for effective separation and exact estimation. (Scheme 1)
Scheme 1.

Drug's molecular structure.
The distinct physicochemical properties of MET and CAM, such as differences in solubility, polarity, and pKa, pose a significant challenge for their simultaneous analysis. Overcoming this requires rigorous optimization of techniques. Among all the established methods, high-performance liquid chromatography (HPLC) is the most suitable due to its flexibility and sensitivity, enabling efficient separation, accurate quantification, and reproducibility in complex drug formulations.
Various techniques of CAM have been used to test their separation and quantification in HPLC [6–9], gas chromatography (GC) [10, 11], and spectrophotometric techniques [12, 13]. It is the hydrophobic nature of CAM and its weakness to alkaline conditions that require particular care in developing the methods. However, the simultaneous analysis of MET and CAM in combined formulations has not been studied widely, and this is despite the fact that such methods are of great clinical and regulatory importance.
Several analytical techniques have been previously reported for the estimation of MET and CAM, yet they suffer from considerable limitations that restrict their application in routine pharmaceutical quality control. UV-spectrophotometric methods, such as those described in Desai [14], lack specificity due to overlapping peaks of absorbance for MET and CAM, leading to poor resolution and false quantitation in matrices that are combined. Fluorescence assays, while being more sensitive, normally come with exceedingly expensive detectors and are also susceptible to matrix interference [8, 14, 15]. GC procedures, such as those of Singh et al. [10, 16]. Entail cumbersome sample preparation procedures, derivatization, and high-temperature conditions that are not appropriate for thermally unstable drugs like MET. Such procedures also use extensive nongreen solvents, thereby posing environmental and safety issues. Voltammetric techniques, as employed by Blazheyevskiy et al. [17–19] in determining MET by N-oxidation with Caroate, are highly sensitive but possess severe practical drawbacks that make them unsuitable for widespread applications. Furthermore, many of the previously published methods either do not conform to green analytical chemistry principles or are not validated according to International Council for Harmonization (ICH) guidelines for parameters such as robustness, specificity, and reproducibility. Existing methods are bereft of statistically optimized chromatographic parameters by response surface methodology (RSM), threatening their validity and utility. Despite wide-ranging therapeutic co-administration of MET and CAM, the literature survey does not reveal any known chromatographic procedures for their simultaneous determination in combined drug formulation dosage forms. Although individual methods for MET or CAM estimation exist, simultaneous HPLC quantitation in a single run was not documented. With increasing emphasis on environmental sustainability in drug analysis, green analytical approaches have been increasingly critical. A green environmental assessment ensures compliance with environmental standards, reduces toxic waste, conserves energy, and enhances laboratory safety. This current study involves a green environmental assessment of an innovative HPLC approach to ensure compliance with environmental and regulatory standards [20]. The primary goal of this research is to develop and finely tune a sensitive, accurate, and durable HPLC method for the quantitative detection and measurement of MET and CAM in combination pharmaceutical products. By establishing a robust analytical method capable of selectively separating and determining both compounds in complex matrices efficiently, to improve pharmaceutical quality control, support comprehensive stability testing, and ensure regulatory compliance. Ultimately, the application of this validated method is expected to enhance the therapeutic benefits and safety of pharmaceutical products containing MET and CAM in the gastrointestinal tract, promoting their wider and more effective use.
2. Materials and Methods
2.1. Materials
Metoclopramide hydrochloride and camylofin dihydrochloride were obtained from Tokyo Chemical Industry Co., Ltd. (TCI), Tokyo, Japan. Ammonium acetate (analytical grade) was purchased from Merck KGaA, Darmstadt, Germany. Ultrapure water (HPLC grade) was obtained using a Milli-Q purification system (Millipore, Bedford, MA, USA). MET hydrochloride and CAM dihydrochloride were obtained from licensed pharmaceutical suppliers SEDICO Pharmaceutical (1st Industrial Zone, 6th of October City, Egypt). Methanol and acetonitrile (HPLC grade, 99.0% purity), glacial acetic acid (99%), and ammonium acetate were procured from Sigma-Aldrich.
2.2. Equipment
Chromatographic analysis was carried out using a Shimadzu HPLC system (Kyoto, Japan) equipped with a UV–visible detector (SPD-20A). The mobile phase was filtered through 0.45 μm nylon membrane filters (Millipore, USA) and degassed using an ultrasonic bath (Elma Elmasonic S 30H, Germany). The pH of the buffer solution was adjusted using a digital pH meter (Mettler Toledo SevenCompact, USA). Sample solutions were mixed and homogenized using a vortex mixer (IKA VORTEX 3, Germany). All weighing operations were carried out using an analytical balance (Sartorius Entris2202-1S, Germany) with 0.1 mg readability to ensure precision.
2.3. Mobile Phase Optimization
The effects of resolution and symmetry in Figure 1 were a very high R2 value and are excellent in model quality. The resolution model has an R2 of 0.9968, whereas the symmetry model has an R2 value of 0.9527; hence, both are strong in predictive capability. Moreover, the predicted R-squared values also match with the adjusted R-squared, which indicates that the models are reliable. Further confirming a strong signal-to-noise ratio, thereby meaning the following models can be applied to optimize mobile phase composition, the Adeq Precision values for the resolution and symmetry model were 62.7445 and 14.1226, respectively. Using the developed model, the optimal conditions concerning the mobile phase would be as described below: buffer concentration: 20 mM (ammonium acetate) 65%; pH: 3.5; Organic ratio: 35%. Under these conditions, resolution and symmetry are balanced properly; therefore, adequate robustness and reproducibility concerning chromatographic performance can be achieved.
Figure 1.

Diagnostic and response surface analysis for resolution (Rs) and symmetry (Sym). This figure presents the statistical evaluation and 3D surface response analysis for resolution (Rs) and symmetry (Sym), (a) normal probability plot for resolution (Rs). (b) 3D surface plot depicting the influence of buffer concentration and organic ratio on resolution (Rs). (c) Normal probability plot of residuals for symmetry (Sym). (d) 3D surface plot showing the effect of buffer concentration and organic ratio on symmetry (Sym).
2.4. Preparation of the Mobile Phase Solutions
The eluent was a mixture of water containing 20 mM ammonium acetate with a pH of 3.5 and methanol in the proportion of 65%:35% (order of aqueous: organic). The pH was set to the proper value with glacial acetic acid. The mobile phase was freshly prepared daily, filtered with a 0.45 μm nylon filter, and degassed before use.
2.5. Chromatographic Conditions
The MET and CAM were resolved under optimized chromatographic conditions using an eluent that contained 20 mM ammonium acetate buffer (pH 3.5) and methanol at a 65:35 aqueous-to-organic ratio. Glacial acetic acid was employed to adjust the pH to 3.5. The mobile phase was prepared fresh daily, filtered using a 0.45 μm nylon membrane, and degassed before use to ensure reproducibility and consistency.
2.6. Validation Parameters
The developed method was validated according to ICH guidelines for specificity, linearity range, accuracy, precision (repeatability and intermediate precision), limit of detection (LOD), limit of quantification (LOQ), robustness, and system suitability.
2.6.1. Specificity
Verified by ensuring no interference from excipients or mobile phase components at the retention times of MET and CAM.
2.6.2. Linearity
Assessed over a concentration range of 0.375–2.7 and 0.625–4.5 μg/mL for MET and CAM, respectively.
2.6.3. Accuracy
Measured as recovery percentages by spiking known concentrations of the analytes into placebo samples.
2.6.4. Precision
Through repeatability (analysis of six replicates of the same concentration on the same day) and intermediate precision obtained on different days.
2.6.5. LOD and LOQ
Calculated by using the signal-to-noise ratio method, where LOD was set at a ratio of 3:1 and LOQ at 10:1.
2.6.6. Robustness
Robustness was verified by introducing small, deliberate variations in flow rate (0.9–1.1 mL/min), column temperature (35–45 °C), and mobile-phase composition; the mobile phase contained 70% buffer with a 60:40 organic-to-aqueous ratio specified where applicable.
2.7. System Suitability
Determined by evaluating parameters such as resolution, tailing factor, and theoretical plates for both analytes.
2.8. Procedure
Twenty microliters of standard or sample solutions were injected into the HPLC system. The peaks were monitored at 230 nm; retention time was recorded for MET and CAM. The analytes were quantified based on their peak areas using calibration curves created from the standard solution.
2.9. Stability Studies
The stability studies to determine the affinity of the analytes in the prepared solution were conducted by storing at room temperature and 40°C for 48 h. Peak areas were simply compared to those at time = 0 h to meet such a degree of significance in degradation nonobservance. This method can allow the accurate, precise, and reproducible determination of MET and CAM in pharmaceutical formulations and is suitable for meeting the stringent requirements of quality control.
2.10. Statistical Analysis
Experiments were carried out in triplicate and presented as mean ± SD. Statistical analysis will be done through SPSS software, Version 25, for the determination of whether the developed HPLC method is reliable and reproducible. Tested statistical tests and parameters in this study will include.
2.11. Validation Parameters
The developed method was validated according to ICH guidelines for specificity, linearity, range, accuracy, precision (repeatability and intermediate precision), LOD, LOQ, robustness, and system suitability.
2.11.1. Specificity
Specificity ensures the method's ability to accurately detect the analytes without interference from excipients or matrix components. It was confirmed by comparing chromatograms of blank, placebo, and spiked samples. The retention times of MET and CAM were clearly distinguishable with no overlapping peaks or background noise, confirming the selective separation of both drugs. This parameter is critical in routine analysis where the presence of formulation additives may otherwise mask or distort the analyte signal.
2.11.2. Linearity
Linearity evaluates how well the method produces results proportional to the analyte concentration. Standard solutions of MET and CAM within their respective ranges were analyzed, and calibration curves were constructed. The regression equations were:
| (1) |
| (2) |
High R2 values indicate excellent correlation and consistent response, confirming the suitability of the method for quantitative analysis across a specified range.
2.11.3. Accuracy
Accuracy refers to the closeness of test results to the true value. This was tested by recovery studies at low, medium, and high concentration levels of MET and CAM. The known amounts were spiked into blank matrices, and the percentage recovery was calculated:
| (3) |
Recovery rates between 98.89% and 102.90% for MET and 100.92%–101.87% for CAM confirm the method's reliability and absence of matrix-related interferences.
2.11.4. Precision
Precision assesses the method's reproducibility under the same conditions over short intervals (repeatability) and across different days (intermediate precision). Six replicate analyses were conducted, and %relative standard deviation (%RSD) was calculated:
| (4) |
The %RSD values remained well below the ICH acceptance limit of 2% [21], demonstrating the method's consistency and suitability for quality control applications requiring high repeatability.
2.11.5. LOD and LOQ
LOD and LOQ represent the smallest concentration of analyte that can be reliably detected or quantified. They were calculated using the standard deviation (σ) of the response and the slope (S) [22]:
| (5) |
| (6) |
The low LOD (0.230 μg/mL for MET, 0.359 μg/mL for CAM) and LOQ (0.692 μg/mL for MET, 1.077 μg/mL for CAM) values highlight the sensitivity of the method for trace-level detection in dosage forms.
2.11.6. Robustness
Robustness measures the method's capacity to remain unaffected by small, deliberate variations in analytical conditions. Flow rate, temperature, and buffer composition were varied slightly within practical ranges. No significant changes were observed in retention time, resolution, or peak shape, indicating reliable method performance. This parameter ensures that the method is applicable under typical laboratory conditions and suitable for routine use.
2.12. System Suitability
System suitability testing was performed to verify the performance and consistency of the chromatographic system before sample analysis. The key parameters evaluated were resolution (Rs), tailing factor (Tf), and theoretical plates (N)—each providing a distinct measure of chromatographic efficiency and separation quality.
Resolution (Rs) indicates the degree of separation between two adjacent peaks and was calculated using:
| (7) |
where t1 and t2 are the retention times of the two peaks, and w1, w2 are their respective baseline widths.
The tailing factor (Tf) assesses peak symmetry and was calculated by:
| (8) |
where W0.05 is the width of the peak at 5% height, and f is the distance from the peak maximum to the leading edge.
Theoretical plates (N) reflect column efficiency and were determined by:
| (9) |
where tR is the retention time and W is the peak width at the baseline.
All results met USP criteria [23]: Rs > 2.0, Tf < 1.5, and N > 3000, confirming the system's robustness, efficiency, and suitability for high-quality chromatographic analysis.
2.13. Comparison of Means
One-way ANOVA was used to compare the differences among the formulations for any statistically significant differences among the samples at a p-value < 0.05 [24]. Afterward, where applicable, post hoc tests (e.g., Tukey's test) were used to identify which groups were statistically different from each other.
2.14. Data Representation
The results were visualized in tables and graphs for clarity, including calibration curves, precision plots, and system suitability parameters. Statistical significance was highlighted in all relevant data points to underline the reliability of the HPLC method for pharmaceutical quality control applications.
3. Results
Chromatographic optimization plays a fundamental role in the development of a robust analytical method by enhancing separation efficiency, improving peak symmetry, and ensuring method reproducibility. In this study, statistical modeling using RSM was applied to evaluate the impact of key variables. RSM was applied for the optimization and development of the reversed-phase high-performance liquid chromatography (RP-HPLC) method for the concurrent estimation of MET and CAM due to its inherent advantages in analytical method development. RSM enables systematic and efficient evaluation of different experimental factors and interactions, which is vital in maximizing chromatographic conditions such as buffer concentration, percent organic solvent, and pH. RSM is distinct from the traditional one-factor-at-a-time approach in that it makes use of statistical modeling to construct predictive equations and response surfaces and thereby determine optimal conditions through reduced experiments and higher confidence in the result. RSM, in this study, enabled the construction of good models with good predictability (R2 of 0.9968 for resolution and 0.9527 for symmetry), thereby enabling the end method to achieve improved separation, peak symmetry, and reproducibility. Use of RSM not only reduced experimental burden and resource usage but also enhanced the robustness, reliability, and ease of feasibility of the method for routine pharmaceutical quality control, as evidenced by successful method validation of the developed HPLC method according to ICH guidelines.
| (10) |
| (11) |
Where:
Y is the predicted response.
A, B, and C are the coded factors for BC, OR, and pH, respectively.
AB, AC, and BC represent interaction terms.
A 2, B2, and C2 are the quadratic terms.
According to equation (1), the obtained data from the regression models show that the resolution is more affected by the organic ratio (B), with the strongest positive effect, followed by the buffer concentration (A) and pH (C). On the other hand, A2 has a strong negative effect: too high buffer concentration decreases the resolution. Regarding equation (2), the symmetry is not greatly influenced by the linear factors; a minor quadratic effect takes place, which stabilizes the response at extreme levels. Interaction terms are not important for either resolution or symmetry.
The obtained data in Figure 1 showed that the organic solvent ratio had the most pronounced positive effect on resolution, followed by buffer concentration and pH. The optimized chromatographic conditions derived from the RSM were 65% aqueous buffer (20 mM ammonium acetate, pH 3.5) and 35% methanol as the organic solvent. These settings provided an excellent balance between resolution and peak symmetry. In this composition, the method achieved optimal separation with minimal tailing and high reproducibility, confirming its robustness and suitability for routine pharmaceutical analysis.
The concurrent quantification of MET and CAM provided the authors with dependable and reproducible results with the optimized RP-HPLC method. The analysis was performed under the chromatographic conditions mentioned in materials and methods, according to good chromatographic resolution, peak symmetry, and retention times.
3.1. Retention Times and Peak Characteristics
Retention times increased to approximately 4.8 and 7.2 min for MET and CAM, respectively. The peaks of both analytes were relatively sharp and symmetric, and all tailing factors were ≤ 1.2, allowing for reliable quantification. The resolution between the two compounds was established as 3.5, which is well above the USP criteria for adequate separation (minimum resolution = 2.0). In agreement with the previously mentioned studies highlighting the efficacy of π–π interactions for resolution analytically (e.g., Hiroshi et al.) [25]. These results demonstrate that the phenyl-hexyl stationary phase is indeed suitable for the separation of compounds with very different polarities.
3.2. Selectivity
The selectivity of the developed method was rigorously evaluated by subjecting MET and CAM to various stress conditions to determine their stability and the method's ability to separate them from their degradation products. For MET, acidic hydrolysis resulted in a new degradation peak at 3.78 min, while the main MET peak remained stable and resolved at 5.8 min (Figure 2(a)). Under alkaline conditions, a similar degradation peak at 3.78 min was observed without interference with the MET peak (Figure 2(b)). Oxidative stress using hydrogen peroxide led to a different degradation product at 7.48 min, and the MET peak remained intact, confirming its selectivity (Figure 2(c)). CAM was also subjected to stress conditions: acidic hydrolysis produced a new degradation peak at 7.75 min, while CAM retained a distinct peak at 9.53 min (Figure 2(d)); under basic conditions, significant degradation was observed, with a major by-product appearing at 2.69 min. Despite this, the CAM peak at 9.58 min remained unaffected (Figure 2(e)). Notably, CAM showed no degradation under oxidative conditions, displaying only a single peak at 9.53 min, suggesting chemical stability in such environments (Figure 2(f)). In addition, the method effectively resolved all degradation products from the parent compounds under each condition. These findings confirm the robustness and specificity of the method, supporting its application in stability-indicating assays. It provides a reliable tool for quality control analysis, capable of distinguishing active pharmaceutical ingredients (APIs) from their degradation products and ensuring drug safety and efficacy throughout shelf life [16].
Figure 2.

(a) Degradation profiles of MET under stress HCl conditions, (b) degradation profiles of MET under stress NaOH conditions, (c) degradation profiles of MET under stress H2O2 conditions, (d) degradation profiles of CAM under stress HCl conditions, (e) degradation profiles of CAM under stress NaOH conditions, and (f) degradation profiles of CAM under stress H2O2 conditions.
3.3. Linearity and Calibration Curves
Both MET and CAM generated linearity in calibration curves as depicted in Figures 2(a), 2(b), 2(c). The standard curve of MET (Figure 3(a)) presented a direct correlation of concentration (0.357–2.7 μg/mL) and peak area, with a regression equation of y = 102.82x + 15.29 and an R2 value of 0.9929, which proved the method for the quantitative determination of MET is fitting both the precision and reliability criteria. The standard curve for CAM (Figure 3(b)) is also an excellent example of linearity at 0.625–4.5 μg/mL, a regression equation of y = 161.14x + 36.73 and an R2 value of 0.9938, which proves the method's stability. Figure 3(c) provides the chromatograph of a combination sample including both MET and CAM at 100% concentration, which exhibits well-separated and distinguishable peaks with a count of about 5.8 min for MET and 9.5 min for CAM. The method was indeed able to accomplish the quantification of both compounds in a single run without any interference, the clear separation of peaks confirms the ability of the method to be accurate. These results, which include correlation coefficient values of more than 0.99, provide a complete assurance of the method's precision, and reproducibility needed for pharmaceutical analysis, in line with earlier work which has shown that the use of buffers in mobile phases increases the linearity of HPLC assays among the benefits (e.g., peak shape improvement and robustness enhanced).
Figure 3.

(a) Standard curves for MET, (b) standard curves for CAM, (c) chromatogram of sample at 100% concentration MIXED with MET and CAM.
3.4. Precision and Accuracy
The precision of the developed method was thoroughly evaluated through intra-day (repeatability) and inter-day (intermediate precision) studies, as summarized in Table 1. Spiked samples at three concentration levels were analyzed: 1.2, 1.5, and 1.8 μg/mL for MET and 2.0, 2.5, and 3.0 μg/mL for CAM. Intra-day results for MET showed excellent recoveries between 101.08% and 101.94%, with %RSD values ranging from 0.72% to 1.07%. CAM recoveries were similarly high, ranging from 101.33% to 101.87%, with %RSD values between 0.82% and 1.97%. Inter-day precision, assessed on separate days, demonstrated strong reproducibility. MET recoveries ranged from 98.89% to 102.90%, with %RSD values from 1.26% to 1.78%, while CAM recoveries ranged from 100.92% to 101.22%, with %RSD between 1.69% and 1.98%. All values fall well within the ICH-accepted criteria, confirming the method's reliability for consistent quantification of both drugs in pharmaceutical preparations under routine analytical conditions [18].
Table 1.
Precision assessment of MET and CAM: repeatability and intermediate precision.
| Analyte | Spiked (μg/mL) | Repeatability | Intermediate precision | ||||
|---|---|---|---|---|---|---|---|
| Measured (μg/mL) ± SD | RSD (%) | Recovery (%) | Measured (μg/mL) ± SD | RSD (%) | Recovery (%) | ||
| MET | 1.2 | 1.21 ± 0.01 | 1.07 | 101.08 | 1.19 ± 0.02 | 1.75 | 98.89 |
| 1.5 | 1.53 ± 0.02 | 0.98 | 101.67 | 1.54 ± 0.02 | 1.26 | 102.90 | |
| 1.8 | 1.84 ± 0.01 | 0.72 | 101.94 | 1.8 ± 0.03 | 1.78 | 100.19 | |
|
| |||||||
| CAM | 2 | 2.04 ± 0.02 | 0.88 | 101.77 | 2.02 ± 0.04 | 1.87 | 101.17 |
| 2.5 | 2.55 ± 0.02 | 0.82 | 101.87 | 2.52 ± 0.05 | 1.98 | 100.92 | |
| 3 | 3.04 ± 0.06 | 1.97 | 101.33 | 3.04 ± 0.05 | 1.69 | 101.22 | |
3.5. LOD and LOQ
The LOD and LOQ were calculated for the developed chromatographic method in order to check the sensitivity and precision of detection and quantification of the analytes. The values of LOD and LOQ for MET were calculated as 0.230 and 0.692 μg/mL, respectively, while for CAM, the LOD was 0.359 mg/mL and the LOQ was 1.077 μg/mL. These values are summarized in Table 2, which highlights the high sensitivity of the method; hence, trace amounts of the analytes can be detected and estimated with high precision. Low value LOD and LOQ refer to the robustness of the present method, quite comparable to most modern sophisticated techniques like UPLC–MS, as reported by Sharma et al. [26]. The high sensitivity is important in the pharmaceutical quality control field, where accurate and reliable measurements are critical for ensuring the safety and efficacy of pharmaceutical products. Very low limits of detection and quantification provide an insight into the applicability of the method in routine analysis that meets almost all the pharmaceutical regulatory standards. The data, which can be found in Table 2, show that the method can support high-quality pharmaceutical testing and research.
Table 2.
Sensitivity parameters of active pharmaceutical ingredients (APIs) for MET and CAM: LOD and LOQ.
| Pharmaceutical ingredient | Sensitivity parameters | |
|---|---|---|
| LOD (μg/mL) | LOQ (μg/mL) | |
| MET | 0.230 | 0.692 |
| CAM | 0.359 | 1.077 |
3.6. Robustness
The robustness of the developed HPLC method was confirmed by introducing minor variations in key parameters, including flow rate, column temperature, and detection wavelength. As detailed in Table 3, recovery values for both MET and CAM remained within acceptable limits across all tested conditions. Temperature shifts (25°C–35°C) and flow rate changes (0.9–1.1 mL/min) produced minimal deviations, with recoveries consistently above 99%. Adjusting detection wavelengths (225–235 nm) also maintained recovery rates within validated thresholds. These findings demonstrate that the method is stable, reproducible, and unaffected by small operational changes, confirming its suitability for routine pharmaceutical analysis and reinforcing its reliability for quality control applications.
Table 3.
Assessment of method robustness: evaluating the impact of chromatographic parameter variations.
| Parameters | Conditions | MET | CAM | ||||
|---|---|---|---|---|---|---|---|
| Area | Con. (mg/mL) | Recovery (%) | Area | Con. (mg/mL) | Recovery (%) | ||
| Column temperature (°C) | 25 | 145.67 | 1.19 | 99.1 ± 0.44 | 376.32 | 2.00 | 99.9 ± 1.16 |
| 30 | 174.75 | 1.50 | 99.7 ± 1.01 | 446.11 | 2.48 | 99.2 ± 0.93 | |
| 35 | 203.14 | 1.80 | 100.1 ± 0.91 | 515.41 | 2.98 | 99.4 ± 0.79 | |
|
| |||||||
| Flow rate (mL/min) | 0.9 | 146.94 | 1.20 | 100.05 ± 1.1 | 378.33 | 2.01 | 100.4 ± 1.28 |
| 1 | 176.14 | 1.51 | 100.5 ± 0.45 | 450.29 | 2.51 | 100.2 ± 0.26 | |
| 1.1 | 201.37 | 1.79 | 99.3 ± 0.53 | 518.67 | 3.00 | 100.07 ± 1.21 | |
|
| |||||||
| Wavelength (nm) | 225 | 146.55 | 1.20 | 99.7 ± 1.16 | 378.40 | 2.01 | 100.4 ± 0.9 |
| 230 | 176.53 | 1.51 | 100.7 ± 0.58 | 452.35 | 2.52 | 100.67 ± 0.6 | |
| 235 | 203.73 | 1.81 | 100.4 ± 0.26 | 516.95 | 2.99 | 99.7 ± 0.76 | |
Note: Mean, SD, n = 3.
3.7. System Suitability
The robustness of the developed method was validated by intentionally introducing small variations into specific chromatographic conditions. Fluctuations in flow rates of ±0.1 mL/min and column temperature of ±2°C had no major effects on the retention times or peak characteristics. System suitability parameters were also satisfied [19], with the two analytes showing over 3000 theoretical plate numbers, with a % RSD of peak area less than 2%. Thus, performing stringent pharmaceutical standards. These results were in agreement with Santali et al. [20]. Table 4 summarizes the result: MET retention time 5.8 min, resolution 17.97, peak symmetry 0.96, and theoretical plate 5440. The retention time for CAM was 9.5 min, and the resolution was 14.39, peak symmetry 0.94, and 8847 theoretical plates.
Table 4.
System suitability results determined for the developed chromatographic method.
| Compound | Retention time (min) | Resolution | Peak symmetry | Theoretical plates |
|---|---|---|---|---|
| MET | 5.8 | 17.97 | 0.96 | 5440 |
| CAM | 9.5 | 14.39 | 0.94 | 8847 |
These results confirm the method meets all acceptance criteria for system suitability. Figures 4(a), 4(b) show chromatograms that further illustrate the reliability and precision of the system. Figure 3(a): chromatogram and system suitability parameters for MET at 100% concentration; Figure 4(b): chromatogram and system suitability parameters for CAM. Both figures give evidence of the method's capability of excellent resolution and peak symmetry, confirming the robustness and suitability of the chromatographic system for routine analysis. These findings collectively validate the method's ability to deliver accurate and reliable results under optimized conditions.
Figure 4.

(a) Chromatogram and system suitability parameters for MET at 100% concentration, (b) chromatogram and system suitability parameters for CAM at 100% concentration.
3.7.1. Concentration
The developed method demonstrated strong robustness and reliability, as confirmed by system suitability testing (Table 4, Figures 3(a) and 3(b)). Minor variations in chromatographic conditions, such as flow rate and column temperature, did not significantly impact performance. System suitability parameters exceeded pharmacopeial standards: MET eluted at 5.8 min (resolution: 17.97; plates: 5440) and CAM at 9.5 min (resolution: 14.39; plates: 8847). These values reflect excellent separation and peak symmetry. The method's validated precision and accuracy support its suitability for routine pharmaceutical quality control and highlight its potential as a robust analytical tool for ensuring drug safety and performance.
3.8. Discussion
Chromatographic methods, especially HPLC, have become an integral part of the pharmaceutical industry for the analysis of a variety of drugs and their formulations. Among them, the quantification of MCP and CAM simultaneously has posed a great challenge due to the considerable difference in their physicochemical properties: MCP is a moderately polar compound, while CAM is a hydrophobic and less polar compound. Separation of the two by HPLC must combine mobile phase composition, column selection, and elution conditions to obtain the best resolution, accuracy, and reproducibility.
Analytical methods play a crucial role in drug safety monitoring, particularly in identifying biochemical alterations associated with adverse drug reactions. As highlighted by Ma et al. [27, 28], the development of predictive models for hepatotoxicity in valproic acid-treated patients relied heavily on precise and validated analytical data, such as transaminase levels, to ensure early detection of liver dysfunction. This underscores the broader importance of robust analytical techniques—not only for pharmacokinetic assessments but also for ensuring the reliability and reproducibility of safety indicators under strict quality control standards. In pharmaceutical quality assurance, such validated methods serve as essential tools to detect subtle but clinically significant deviations that may compromise patient safety or therapeutic efficacy.
As articles detail, several studies have focused on HPLC method optimization for determining paracetamol and CAM in different pharmaceutical dosage forms. Hussien et al. [29, 30] developed a simple HPLC method for determining serum paracetamol levels. The study showed linearity and precision within the range of this method. RP-HPLC was also used to analyze paracetamol and gave good resolution and linearity from oral preparations. Various RP-HPLC methods for CAM have also been validated and provided excellent precision and sensitivity [7]. The “green” solvents, with the example of ethanol, besides the previous achievements, were also tried as a step toward the idea of a green analytical method [31]. The mobile phase described here contains a 65%:35% part of the water-organic composition with 20 mM ammonium acetate buffer, pH 3.5, and methanol, which is the solvent for both MET and CAM substances and the one that can be separated. However, several decisions were made in this development that caused the final performance of the method to be subject to some difficulties.
3.9. Buffer Capacity and Stability
The buffer-ammonium acetate at pH 3.5 probably has a serious drawback concerning buffer capacity, especially in long runs and/or when real biological matrices have to be analyzed. This would lead to shifting retention times during the course of time and thus diminish the reproducibility of such an analysis. This aspect plays an important role in the case of high-throughput or long-time applications. According to Dolan [32, 33], the pH of the mobile phase should be kept constant for the consistency of retention times and selectivity, since a slight change in pH can result in detrimental effects on the chromatographic separation.
3.10. Organic Solvent Use
The presence of methanol in the mobile phase is ideal for increasing the solubility and resolution of hydrophobic compounds such as CAM. However, methanol has a high evaporation rate; this can, over time, change the composition of the mobile phase and affect the accuracy and reproducibility of the results. This problem is compounded in large-scale production settings where continuous analysis may lead to solvent evaporation and frequent adjustments in the mobile-phase composition. Zhang et al. [34] stated that volatile organic solvents create problems in maintaining stable mobile-phase conditions that may affect the robustness of the separation.
3.11. Column Selection and Resolution
The use of a phenyl-hexyl column with the dimensions of 150 × 4.6 mm and a particle size of 5 μm is very instrumental in the selection of the current method in view for the separation of MET and CAM. This column is designed to take advantage of hydrophobic interactions and π–π stacking, making it ideal for the separation of aromatic and moderately polar compounds. However, this column is very questionable, being able to retain this kind of effectiveness when dealing with such vastly different polarities between the compounds in question. CAM is aromatic as well but more hydrophobic compared to MET. It can be argued that such polar and nonpolar compounds can be poorly separated by a phenyl-hexyl column. Wang et al. [35] noted that columns optimized for aromatic compounds might achieve high resolution poorly in cases of separating compounds of highly different physicochemical properties.
The second reason, even though the method reported a good separation, is that it cannot attain the highest resolution when some of the test compounds are very similar in structure or even closer in polarity. Chen et al. [36] have pointed out that sometimes one stationary phase is not enough to provide the best separation for compounds that have only subtle differences in chemical structure. This may be a problem with more complex mixtures, where resolution between peaks may be poor.
3.12. Potential Column Overload
Another problem relating to column choice is column overload, since high analyte concentrations may be present. The method described herein uses a relatively high flow of 1 mL/min and quite a large column size (150 mm in length). All these further increase the possibilities of this problem: poor peak shape, distorted chromatograms, and consequently, loss of resolution. Zhang et al. [37] express that high concentrations of an analyte together with high flow rates may result in poor column performance and nonlinear responses and thus seriously compromise the accuracy and precision of the analysis.
3.13. Isocratic Elution and Column Stability
The approach involves isocratic elution, meaning that the composition of the mobile phase used in the separation is constant throughout. Isocratic elution is simple and effective, while the separation is stable; it may not be a better option in cases where retention times for the compounds to be separated are too different. Generally speaking, isocratic conditions are best for cases where the analytes are eluted approximately at the same time. In such cases where the retention range of the analytes is very wide, optimal separation is not possible through isocratic elution. According to Gupta and Sharma [38–40], such cases may allow more flexibility with gradient elution since, during the course of separation, the composition of the mobile phase is varied, and this gives better resolution for compounds with different retention times.
Furthermore, the isocratic conditions, such as methanol, that are used can quicken the deterioration of the stationary phase. The constant presence of a high amount of organic solvents in the column can eventually cause it to break down, hence the peak tailing, resolution loss, and retention time shifts will happen. Kim and Lee point out that among the most critical factors, the integrity of a column can be compromised because of the organic solvents, and that if the latter are essential, different organic solvents can be used [41]. Separation efficiency is improved with a better alternative to column longevity gradient elution.
3.14. Method Robustness and Reproducibility
The method is claimed to have the power of resistance as its main feature [42, 43]. However, the functioning of a method under small changes in the chromatographic conditions must be considered. Small changes in column temperature, solvent composition, or flow rate might cause shifts in retention time or resolution. This is particularly the case for phenyl-hexyl columns, which are sensitive to temperature and solvent composition variations. Even slight changes in the conditions could result in peak shape changes and separation efficiency. Zhang et al. [44, 45] observed that though chromatographic methods are effective under controlled conditions, they may reveal variability when exposed to environmental changes and thus call for wider condition validation.
Furthermore, although the method reports good precision, that does not necessarily guarantee stability in the long run when applied in different laboratories or with different instruments. Any variation in laboratory conditions, equipment calibration, or solvent purity might affect the reproducibility and reliability of the results. The robustness of the method has therefore to be strictly tested under various setups and operational conditions for consistent performance. It is particularly crucial for quality control applications, in which the reliability of methods should be ensured with time and within different operational settings.
4. Assessment of Greenness for the Analytical Method
Eco-scale is the analytical tool that provides a grading system for the environmental impact assessment of analytical methods. Several approaches are used for ascertaining how green a procedure is, of which the semi-quantitative approach is gaining currency. It adopts four criteria: type of toxic/hazardous materials and quantity used, amount of waste produced, and the energy consumed [46]. This simultaneous chromatographic analysis of MET and CAM represents the new trend in modern analytical chemistry, which is targeted toward eco-friendliness without compromising the high level of analytical performance. The proposed method can be considered green with an AGREE score of 0.62, as depicted in Figure 5 [47], reflecting low waste generation, less use of hazardous reagents, and judicious use of energy. It puts the methodology as an eco-friendly alternative to the conventional chromatographic methods, normally resource-intensive in their steps. This is further evidenced by the very high Blue Applicability Grade Index score of 75.0 [48, 49], highlighting the broad analytical situations in which the method would be adaptable and practically useful. It reflects the method's capability for optimization in key parameters, sample treatment, reduced derivatization requirements, operator safety, and energy efficiency.
Figure 5.

Evaluation of an eco-friendly approach utilizing AGREE software.
It provides state-of-the-art chromatographic analysis of compounds in a single run without sacrificing accuracy or sensitivity. This efficiency reduces the resource intensity often associated with discrete analyses, emphasizing its practical application in routine laboratory operations. The method underscores the trend toward sustainability in pharmaceutical and chemical analysis and provides a model for the development of other methods designed to balance analytical accuracy with environmental stewardship [50, 51]. This dual emphasis on green chemistry and practical applicability places analytical science at a progressive stride toward global sustainability.
5. Conclusion
The optimized HPLC method for the simultaneous analysis of MET and CAM has been proven to have good resolution, precision, and sensitivity. Thus, it also has some advantages but a few disadvantages. The main drawbacks are in the buffer capacity, the right solvent, and their management; hence, the right selection of the column and elution conditions is required. Method robustness, resolution, and long-term reliability could be improved only if the problems were answered by method optimization or the introduction of more flexible conditions of chromatography, such as gradient elution or different stationary phases. Besides these, careful control of result stability and reproducibility in changing conditions, which is quite important in pharmaceutical analysis and quality control of such a method, is required.
Acknowledgments
The authors gratefully acknowledge the funding of the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, through project number: (RG24-S023).
Funding Statement
This research was funded by the Deanship of Graduate Studies and Scientific Research, Jazan University, Saudi Arabia, through project number: (RG24-S023).
Data Availability Statement
Data will be made available upon request.
Disclosure
All authors have read and agreed to the published version of the manuscript.
Conflicts of Interest
The authors declare no conflicts of interest.
Author Contributions
Ahmed Hussain Jawhari: writing–review and editing, methodology, software, and formal analysis. Zeinhom H. Mohamed: writing–review and editing, software, data curation, and writing–original draft preparation.
References
- 1.WHO Organization. Acupuncture: Review and Analysis of Reports on Controlled Clinical Trials. 2002.
- 2.Cao D.-F., Zhou X. Y., Guo Q., et al. Unveiling the Role of Histone Deacetylases in Neurological Diseases: Focus on Epilepsy. Biomarker Research . 2024;12(1):p. 142. doi: 10.1186/s40364-024-00687-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Huang H., Liao Y., Yu Y., Qin H., Wei Y. Z., Cao L. Adult-Onset Neuronal Ceroid Lipofuscinosis Misdiagnosed as Autoimmune Encephalitis and Normal-Pressure Hydrocephalus: A 10-Year Case Report and Case-Based Review. Medicine . 2024;103(43):p. e40248. doi: 10.1097/md.0000000000040248. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Saito M., Shibata O., Yamaguchi M., et al. Metoclopramide Causes Airway Smooth Muscle Relaxation Through Inhibition of Muscarinic M3 Receptor in the Rat Trachea. Anesthesia & Analgesia . 2004;98(5):1325–1329. doi: 10.1213/01.ane.0000111104.33104.51. [DOI] [PubMed] [Google Scholar]
- 5.Liu Y., Yao X., Song L., et al. Metabolites Characterization of a Novel DPP-4 Inhibitor, Imigliptin in Humans and Rats Using Ultra-High Performance Liquid Chromatography Coupled With Synapt High-Resolution Mass Spectrometry. Journal of Pharmaceutical and Biomedical Analysis . 2018;157:189–200. doi: 10.1016/j.jpba.2018.05.029. [DOI] [PubMed] [Google Scholar]
- 6.Kokilambigai K., Lakshmi K. Camylofin Dihydrocloride–A Review of Analytical Methods. Sciences . 2014;1:1332–1343. [Google Scholar]
- 7.Singh R. K. R., Rathnam M. V., Singh S. J., Vegesna R. V. Stability Indicating Method for Simultaneous RP HPLC Determination of Camylofin Dihydrochloride and Nimesulide in Pharmaceutical Preparations. ISRN Analytical Chemistry . 2012;2012(1):1–7. doi: 10.5402/2012/586415. [DOI] [Google Scholar]
- 8.Makwana S., Patel M., Prajapati D., Shingala C., Upadhyay J., Shah A. Validated Stability Indicating Chromatographic Method for the Simultaneous Estimation of Camylofin With NSAID Drugs and a New Approach of Method Transfer From Classical HPLC to a Modern UPLC Instrument. Chromatography Research International . 2016;2016(1):1596021–1596027. doi: 10.1155/2016/1596021. [DOI] [Google Scholar]
- 9.Atta A. M., Gomaa M. S., Salama I., Mostafa S. M. Comparative Study of New HPLC and HPTLC Methods for Simultaneous Determination of Dipyrone and Camylofin Dihydrochloride Using Hyoscine Butyl Bromide as Internal Standard. IOSR Journal of Pharmacy and Biological Sciences . 2016;11(04):36–46. doi: 10.9790/3008-1104043646. [DOI] [Google Scholar]
- 10.Singh R. K. R., Rathnam M. V., Singh S. J., Vegesna R. V. Determination of Camylofin Dihydrochloride and Nimesulide in Pharmaceutical Preparation by Gas Chromatography. American Journal of Analytical Chemistry . 2011;02(08):944–952. doi: 10.4236/ajac.2011.28110. [DOI] [Google Scholar]
- 11.Singh R. R., Rathnam M. V., Singh S. J., Vegesna R. V. A Stability Indicating gc-fid Method for Camylofin Dihydrochloride and Diclofenac Potassium in Pharmaceutical Preparation. International Journal of Pharmacy and Pharmaceutical Sciences . 2012;4(1):317–324. [Google Scholar]
- 12.Abbas A. E. F., Abdelshafi N. A., Gamal M., et al. Simultaneously Quantifying a Novel Five-Component Anti-Migraine Formulation Containing Ergotamine, Propyphenazone, Caffeine, Camylofin, and Mecloxamine Using UV Spectrophotometry and Chemometric Models. BMC chemistry . 2024;18(1):p. 233. doi: 10.1186/s13065-024-01339-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Patil S., Khaire M., Rane S. S., Choudhari R. Y., Fegade S. Simultaneous Spectrophotometric Estimation of Camylofin Dihydrochloride and Diclofenac Potassium in Tablet Dosage Form
- 14.Desai M. Chlorphenarimine Maleate and Phenylephrine in Tablet Dosage Formulation . Institute of Pharmacy, Nirma University; 2017. Development and Validation of Stability Indicating HPLC Method for Simultaneous Estimation of Acetamenophene. [Google Scholar]
- 15.Rathnam M. V., Singh R. R. Simultaneous RP HPLC Determination of Camylofin Dihydrochloride and Diclofenac Potassium in Pharmaceutical Preparations. Pharmaceutica Analytica Acta . 2010;01(02):1–4. doi: 10.4172/2153-2435.1000108. [DOI] [Google Scholar]
- 16.Jones R. D., Blanton C. D., Bowen J. M. Identification of Metoclopramide Metabolites in the Urine of Cattle by Gas Chromatography-Mass Spectrometry and High-Performance Liquid chromatography-Photodiode Array Detection. Veterinary Research Communications . 1993;17(5):387–396. doi: 10.1007/bf01839389. [DOI] [PubMed] [Google Scholar]
- 17.Sawan H. S., Merey H. A., Mahmoud A. M., Atty S. A. Electrochemical Sensor Based on ZrO2/Ionic Liquid for Ultrasensitive Simultaneous Determination of Metoclopramide and Paracetamol in Biological Fluids. Journal of Applied Electrochemistry . 2023;54(3):703–718. doi: 10.1007/s10800-023-01982-0. [DOI] [Google Scholar]
- 18.Dejmkova H., Dag C., Barek J., Zima J. D. I. Voltammetric and Amperometric Determination of Metoclopramide on Boron-Doped Diamond Film Electrode. Open Chemistry . 2012;10(4):1310–1317. doi: 10.2478/s11532-012-0056-8. [DOI] [Google Scholar]
- 19.Guo W., Geng M., Zhou L. Electrochemistry of Metoclopramide at Multi-Walled Carbon Nanotube Modified Electrode and Its Voltammetric Detection. Analytical Sciences . 2012;28(7):693–698. doi: 10.2116/analsci.28.693. [DOI] [PubMed] [Google Scholar]
- 20.Santali E. Y., Naguib I. A., Alshehri A. M., et al. Greenness Assessment of Chromatographic Methods Used for Analysis of Empagliflozin: a Comparative Study. Separations . 2022;9(10):p. 275. doi: 10.3390/separations9100275. [DOI] [Google Scholar]
- 21.Navas N., Herrera A., Martínez-Ortega A., Salmerón-García A., Cabeza J., Cuadros-Rodríguez L. Quantification of an Intact Monoclonal Antibody, Rituximab, by (RP) HPLC/DAD in Compliance With ICH Guidelines. Analytical and Bioanalytical Chemistry . 2013;405(29):9351–9363. doi: 10.1007/s00216-013-7368-1. [DOI] [PubMed] [Google Scholar]
- 22.Taleuzzaman M. Limit of Blank (LOB), Limit of Detection (LOD), and Limit of Quantification (LOQ) Organic & Medicinal Chemistry International Journal . 2018;7(5):127–131. doi: 10.19080/omcij.2018.07.555722. [DOI] [Google Scholar]
- 23.Li Z. Hightthroughput Analysis in the Pharmaceutical Industry . 2009. 9 High-Throughput Analysis in Support of Process Chemistry and Formulation Research and Development in the Pharmaceutical Industry; p. p. 247. [Google Scholar]
- 24.Patel M. P., Desai K. N., Sangani M. Development, Validation and Comparison of RP-HPLC and UV Methods Using Statistical Analysis One Way Anova Test for Repaglinide in Formulation. Indian Drugs . 2023;60(09):87–92. doi: 10.53879/id.60.09.13574. [DOI] [Google Scholar]
- 25.Kobayashi H., Okada K., Tokuda S., et al. Separation of Saccharides Using Fullerene-Bonded Silica Monolithic Columns via Π Interactions in Liquid Chromatography. Scientific Reports . 2020;10(1):13850. doi: 10.1038/s41598-020-70904-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Sharma P., Kumar D., Mutnuri S. UPLC–MS/MS Method Validation of Ciprofloxacin in Human Urine: Application to Biodegradability Study in Microbial Fuel Cell. Biomedical Chromatography . 2019;33(2):p. e4392. doi: 10.1002/bmc.4392. [DOI] [PubMed] [Google Scholar]
- 27.Niu H., Alvarez‐Alvarez I., Chen M. Artificial Intelligence: An Emerging Tool for Studying Drug-Induced Liver Injury. Liver International . 2025;45(3):p. e70038. doi: 10.1111/liv.70038. [DOI] [PubMed] [Google Scholar]
- 28.Ma H., Huang S., Li F., et al. Development and Validation of an Automatic Machine Learning Model to Predict Abnormal Increase of Transaminase in Valproic Acid-Treated Epilepsy. Archives of Toxicology . 2024;98(9):3049–3061. doi: 10.1007/s00204-024-03803-5. [DOI] [PubMed] [Google Scholar]
- 29.Kudyar P., Raj J. P., Kulkarni A. A., Raju A. P., Mallayasamy S., Mohanraj K. A Pharmacokinetic Profiling Study After Single-Tablet Regimen of Camylofin 50 mg and Paracetamol 325 mg in Healthy Participants. Indian Journal of Physiology & Pharmacology . 2024;68:183–188. doi: 10.25259/ijpp_86_2024. [DOI] [Google Scholar]
- 30.Slørdal L., Prytz P. S., Aasebø U., Aarbakke J. A Simple HPLC Method for Measuring Metoclopramide in Serum. Acta Pharmacologica et Toxicologica . 1986;58(3):240–242. doi: 10.1111/j.1600-0773.1986.tb00101.x. [DOI] [PubMed] [Google Scholar]
- 31.Demir İ., Bulduk İ., Enginar H., Çifci C. A Green HPLC Method for Determination of Mirtazapine in Pharmaceutical Products: Development, Validation, and Greenness Assessment. Acta Chromatographica . 2024;36(3):237–246. doi: 10.1556/1326.2023.01155. [DOI] [Google Scholar]
- 32.de Oliveira L. F., Dolan E., Swinton P. A., et al. Extracellular Buffering Supplements to Improve Exercise Capacity and Performance: A Comprehensive Systematic Review and Meta-Analysis. Sports Medicine . 2022;52(3):505–526. doi: 10.1007/s40279-021-01575-x. [DOI] [PubMed] [Google Scholar]
- 33.Saunders B., Elliott-Sale K., Artioli G. G., et al. β-Alanine Supplementation to Improve Exercise Capacity and Performance: A Systematic Review and Meta-Analysis. British Journal of Sports Medicine . 2017;51(8):658–669. doi: 10.1136/bjsports-2016-096396. [DOI] [PubMed] [Google Scholar]
- 34.Zhang M., Zhang X., Liu Y., et al. Insights Into the Relationships Between Physicochemical Properties, Solvent Performance, and Applications of Deep Eutectic Solvents. Environmental Science and Pollution Research . 2021;28(27):35537–35563. doi: 10.1007/s11356-021-14485-2. [DOI] [PubMed] [Google Scholar]
- 35.Wang C., Gong M., Zhang M., Chan Y. Unsupervised Hyperspectral Image Band Selection via Column Subset Selection. IEEE Geoscience and Remote Sensing Letters . 2015;12(7):1411–1415. doi: 10.1109/lgrs.2015.2404772. [DOI] [Google Scholar]
- 36.Chen S.-L., Villaverde J. F., Lee H. Y., et al. A Power-Efficient Mixed-Signal Smart ADC Design With Adaptive Resolution and Variable Sampling Rate for Low-Power Applications. IEEE Sensors Journal . 2017;17(11):3461–3469. doi: 10.1109/jsen.2017.2680472. [DOI] [Google Scholar]
- 37.Zhang C., Li S., Wu J., et al. Developing a Hydroxyl-Functionalized Magnetic Porous Organic Polymer Combined With HPLC-MS/MS for Determining 31 Amide Herbicides in Fruit Wine. Food Chemistry . 2023;403:p. 134442. doi: 10.1016/j.foodchem.2022.134442. [DOI] [PubMed] [Google Scholar]
- 38.Nikitas P., Pappa-Louisi A. Expressions of the Fundamental Equation of Gradient Elution and a Numerical Solution of These Equations Under Any Gradient Profile. Analytical Chemistry . 2005;77(17):5670–5677. doi: 10.1021/ac0506783. [DOI] [PubMed] [Google Scholar]
- 39.Gupta V., Beirne S., Nesterenko P. N., Paull B. Investigating the Effect of Column Geometry on Separation Efficiency Using 3D Printed Liquid Chromatographic Columns Containing Polymer Monolithic Phases. Analytical Chemistry . 2018;90(2):1186–1194. doi: 10.1021/acs.analchem.7b03778. [DOI] [PubMed] [Google Scholar]
- 40.Sharma S., Sharma Y. P., Bhardwaj C. Development and Validation of HPLC-UV Method for Quantification of Podophyllotoxin in Podophyllum hexandrum Royle. Journal of Pharmacognosy and Phytochemistry . 2018;7(2):3748–3752. [Google Scholar]
- 41.Mathew E. M., Lewis L., Rao P., Nalini K., Kamath A., Moorkoth S. Novel HILIC-ESI-MS Method for Urinary Profiling of MSUD and Methylmalonic Aciduria Biomarkers. Journal of Chromatographic Science . 2019;57(8):715–723. doi: 10.1093/chromsci/bmz045. [DOI] [PubMed] [Google Scholar]
- 42.Christian J., G Patel K., Gandhi T. Validation and Experimental Design Assisted Robustness Testing of RPLC Method for the Simultaneous Analysis of Brinzolamide and Brimonidine Tartrate in an Ophthalmic Dosage Form. Indian Journal of Pharmaceutical Sciences . 2016;78(5):631–640. doi: 10.4172/pharmaceutical-sciences.1000162. [DOI] [Google Scholar]
- 43.Dejaegher B., Heyden Y. V. Ruggedness and Robustness Testing. Journal of Chromatography A . 2007;1158(1-2):138–157. doi: 10.1016/j.chroma.2007.02.086. [DOI] [PubMed] [Google Scholar]
- 44.Zhang J., Chen Z. Metal-Organic Frameworks as Stationary Phase for Application in Chromatographic Separation. Journal of Chromatography A . 2017;1530:1–18. doi: 10.1016/j.chroma.2017.10.065. [DOI] [PubMed] [Google Scholar]
- 45.Faraji N., Zhang Y., K Ray A. Impact of Operating Conditions on Chromatographic Column Performance: Experimental Studies on Adsorption of High-Value Minor Whey Proteins. Aims Bioengineering . 2017;4(2):223–238. doi: 10.3934/bioeng.2017.2.223. [DOI] [Google Scholar]
- 46.Gałuszka A., Migaszewski Z. M., Konieczka P., Namieśnik J. Analytical Eco-Scale for Assessing the Greenness of Analytical Procedures. TrAC, Trends in Analytical Chemistry . 2012;37:61–72. doi: 10.1016/j.trac.2012.03.013. [DOI] [Google Scholar]
- 47.Pena-Pereira F., Wojnowski W., Tobiszewski M. AGREE—Analytical Greenness Metric Approach and Software. Analytical Chemistry . 2020;92(14):10076–10082. doi: 10.1021/acs.analchem.0c01887. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Płotka-Wasylka J. A New Tool for the Evaluation of the Analytical Procedure: Green Analytical Procedure Index. Talanta . 2018;181:204–209. doi: 10.1016/j.talanta.2018.01.013. [DOI] [PubMed] [Google Scholar]
- 49.Salem H., Algethami F. K., Magdy M. A., et al. High Performance Thin Layer Chromatography (HPTLC) Analysis of Anti-Asthmatic Combination Therapy in Pharmaceutical Formulation: Assessment of the Method’s Greenness and Blueness. Pharmaceuticals . 2024;17:1002–1020. doi: 10.3390/ph17081002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Abdelfatah R. M., Tohamy S. I., Elsayed M. A., Magdy M. A. Greenness and Practicability Assessment of a New HPLC-DAD Method for Simultaneous Determination of Three Drugs Used for a Triple-Therapy Regimen for Helicobacter Pylori and Application to a Pharmacokinetic Study. Microchemical Journal . 2024;205:111255. doi: 10.1016/j.microc.2024.111255. [DOI] [Google Scholar]
- 51.Pragathi Y., Yenduri S., Yenduri S. Assessing Environmental Sustainability of HPLC Methods for Tri-Combination Anti-Hypertensive Drug Analysis. Green Analytical Chemistry . 2025;12:p. 100182. doi: 10.1016/j.greeac.2024.100182. [DOI] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data will be made available upon request.
